000 01496 a2200445 4500
005 20250512012346.0
264 0 _c19890601
008 198906s 0 0 eng d
022 _a0041-1345
040 _aNLM
_beng
_cNLM
100 1 _aCantarovich, D
245 0 0 _aAnti-IL2 receptor monoclonal antibody (33B3.1) in prophylaxis of early kidney rejection in humans: a randomized trial versus rabbit antithymocyte globulin.
_h[electronic resource]
260 _bTransplantation proceedings
_cFeb 1989
300 _a1769-71 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xadverse effects
650 0 4 _aAntilymphocyte Serum
_xadverse effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aCommunicable Diseases
_xetiology
650 0 4 _aFemale
650 0 4 _aGraft Rejection
650 0 4 _aHumans
650 0 4 _aInterleukin-2
_ximmunology
650 0 4 _aKidney Transplantation
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRabbits
_ximmunology
650 0 4 _aRandom Allocation
650 0 4 _aReceptors, Interleukin-2
_ximmunology
700 1 _aLe Mauff, B
700 1 _aHourmant, M
700 1 _aGiral, M
700 1 _aDenis, M
700 1 _aJacques, Y
700 1 _aSoulillou, J P
773 0 _tTransplantation proceedings
_gvol. 21
_gno. 1 Pt 2
_gp. 1769-71
999 _c2658471
_d2658471